Kidney and Liver Tissue Tacrolimus Concentrations in Adult Transplant Recipients—The Influence of the Whole Blood and Tissue Concentrations on Efficiency of Treatment during Immunosuppressive Therapy

Tacrolimus (TAC) has a narrow therapeutic index and highly variable pharmacokinetic characteristics. Close monitoring of the TAC concentrations is required in order to avoid the risk of acute rejection or adverse drug reaction. The results in some studies indicate that inter-tissue TAC concentration...

Full description

Bibliographic Details
Main Authors: Magdalena Bodnar-Broniarczyk, Magdalena Durlik, Teresa Bączkowska, Katarzyna Czerwińska, Ryszard Marszałek, Tomasz Pawiński
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/10/1576
_version_ 1797513419419549696
author Magdalena Bodnar-Broniarczyk
Magdalena Durlik
Teresa Bączkowska
Katarzyna Czerwińska
Ryszard Marszałek
Tomasz Pawiński
author_facet Magdalena Bodnar-Broniarczyk
Magdalena Durlik
Teresa Bączkowska
Katarzyna Czerwińska
Ryszard Marszałek
Tomasz Pawiński
author_sort Magdalena Bodnar-Broniarczyk
collection DOAJ
description Tacrolimus (TAC) has a narrow therapeutic index and highly variable pharmacokinetic characteristics. Close monitoring of the TAC concentrations is required in order to avoid the risk of acute rejection or adverse drug reaction. The results in some studies indicate that inter-tissue TAC concentrations can be a better predictor with regards to acute rejection episode than TAC concentration in whole blood. Therefore, the aim of the study was to assess the correlation between dosage, blood, hepatic and kidney tissue concentration of TAC measured by a validated liquid chromatography tandem mass spectrometry (LC-MS/MS) and clinical outcomes in a larger cohort of 100 liver and renal adult transplant recipients. Dried biopsies were weighed, mechanically homogenized and then the samples were treated with a mixture of zinc sulfate—acetonitrile to perform protein precipitation. After centrifugation, the extraction with <i>tert</i>-butyl methyl ether was performed. The analytical range was proven for TAC tissue concentrations of 10–400 pg/mg. The accuracy and precision fell within the acceptance criteria for intraday as well as interday assay. There was no correlation between dosage, blood (C<sub>0</sub>) and tissue TAC concentrations. TAC concentrations determined in liver and kidney biopsies ranged from 8.5 pg/mg up to 160.0 pg/mg and from 7.1 pg/mg up to 215.7 pg/mg, respectively. To the best of our knowledge, this is the first LC-MS/MS method for kidney and liver tissue TAC monitoring using Tac<sup>13</sup>C,D<sub>2</sub> as the internal standard, which permits measuring tissue TAC concentrations as low as 10 pg/mg.
first_indexed 2024-03-10T06:16:20Z
format Article
id doaj.art-8085468a116040dabed66bdf13854e14
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T06:16:20Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-8085468a116040dabed66bdf13854e142023-11-22T19:37:50ZengMDPI AGPharmaceutics1999-49232021-09-011310157610.3390/pharmaceutics13101576Kidney and Liver Tissue Tacrolimus Concentrations in Adult Transplant Recipients—The Influence of the Whole Blood and Tissue Concentrations on Efficiency of Treatment during Immunosuppressive TherapyMagdalena Bodnar-Broniarczyk0Magdalena Durlik1Teresa Bączkowska2Katarzyna Czerwińska3Ryszard Marszałek4Tomasz Pawiński5Department of Drug Chemistry, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, PolandDepartment of Transplantation Medicine, Nephrology and Internal Medicine, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warsaw, PolandDepartment of Transplantation Medicine, Nephrology and Internal Medicine, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warsaw, PolandDepartment of Transplantation Medicine, Nephrology and Internal Medicine, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warsaw, PolandDepartment of Drug Bioanalysis and Analysis, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, PolandDepartment of Drug Chemistry, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, PolandTacrolimus (TAC) has a narrow therapeutic index and highly variable pharmacokinetic characteristics. Close monitoring of the TAC concentrations is required in order to avoid the risk of acute rejection or adverse drug reaction. The results in some studies indicate that inter-tissue TAC concentrations can be a better predictor with regards to acute rejection episode than TAC concentration in whole blood. Therefore, the aim of the study was to assess the correlation between dosage, blood, hepatic and kidney tissue concentration of TAC measured by a validated liquid chromatography tandem mass spectrometry (LC-MS/MS) and clinical outcomes in a larger cohort of 100 liver and renal adult transplant recipients. Dried biopsies were weighed, mechanically homogenized and then the samples were treated with a mixture of zinc sulfate—acetonitrile to perform protein precipitation. After centrifugation, the extraction with <i>tert</i>-butyl methyl ether was performed. The analytical range was proven for TAC tissue concentrations of 10–400 pg/mg. The accuracy and precision fell within the acceptance criteria for intraday as well as interday assay. There was no correlation between dosage, blood (C<sub>0</sub>) and tissue TAC concentrations. TAC concentrations determined in liver and kidney biopsies ranged from 8.5 pg/mg up to 160.0 pg/mg and from 7.1 pg/mg up to 215.7 pg/mg, respectively. To the best of our knowledge, this is the first LC-MS/MS method for kidney and liver tissue TAC monitoring using Tac<sup>13</sup>C,D<sub>2</sub> as the internal standard, which permits measuring tissue TAC concentrations as low as 10 pg/mg.https://www.mdpi.com/1999-4923/13/10/1576tacrolimuskidney and liver transplantationtissue concentrationLC-MS/MSTDM
spellingShingle Magdalena Bodnar-Broniarczyk
Magdalena Durlik
Teresa Bączkowska
Katarzyna Czerwińska
Ryszard Marszałek
Tomasz Pawiński
Kidney and Liver Tissue Tacrolimus Concentrations in Adult Transplant Recipients—The Influence of the Whole Blood and Tissue Concentrations on Efficiency of Treatment during Immunosuppressive Therapy
Pharmaceutics
tacrolimus
kidney and liver transplantation
tissue concentration
LC-MS/MS
TDM
title Kidney and Liver Tissue Tacrolimus Concentrations in Adult Transplant Recipients—The Influence of the Whole Blood and Tissue Concentrations on Efficiency of Treatment during Immunosuppressive Therapy
title_full Kidney and Liver Tissue Tacrolimus Concentrations in Adult Transplant Recipients—The Influence of the Whole Blood and Tissue Concentrations on Efficiency of Treatment during Immunosuppressive Therapy
title_fullStr Kidney and Liver Tissue Tacrolimus Concentrations in Adult Transplant Recipients—The Influence of the Whole Blood and Tissue Concentrations on Efficiency of Treatment during Immunosuppressive Therapy
title_full_unstemmed Kidney and Liver Tissue Tacrolimus Concentrations in Adult Transplant Recipients—The Influence of the Whole Blood and Tissue Concentrations on Efficiency of Treatment during Immunosuppressive Therapy
title_short Kidney and Liver Tissue Tacrolimus Concentrations in Adult Transplant Recipients—The Influence of the Whole Blood and Tissue Concentrations on Efficiency of Treatment during Immunosuppressive Therapy
title_sort kidney and liver tissue tacrolimus concentrations in adult transplant recipients the influence of the whole blood and tissue concentrations on efficiency of treatment during immunosuppressive therapy
topic tacrolimus
kidney and liver transplantation
tissue concentration
LC-MS/MS
TDM
url https://www.mdpi.com/1999-4923/13/10/1576
work_keys_str_mv AT magdalenabodnarbroniarczyk kidneyandlivertissuetacrolimusconcentrationsinadulttransplantrecipientstheinfluenceofthewholebloodandtissueconcentrationsonefficiencyoftreatmentduringimmunosuppressivetherapy
AT magdalenadurlik kidneyandlivertissuetacrolimusconcentrationsinadulttransplantrecipientstheinfluenceofthewholebloodandtissueconcentrationsonefficiencyoftreatmentduringimmunosuppressivetherapy
AT teresabaczkowska kidneyandlivertissuetacrolimusconcentrationsinadulttransplantrecipientstheinfluenceofthewholebloodandtissueconcentrationsonefficiencyoftreatmentduringimmunosuppressivetherapy
AT katarzynaczerwinska kidneyandlivertissuetacrolimusconcentrationsinadulttransplantrecipientstheinfluenceofthewholebloodandtissueconcentrationsonefficiencyoftreatmentduringimmunosuppressivetherapy
AT ryszardmarszałek kidneyandlivertissuetacrolimusconcentrationsinadulttransplantrecipientstheinfluenceofthewholebloodandtissueconcentrationsonefficiencyoftreatmentduringimmunosuppressivetherapy
AT tomaszpawinski kidneyandlivertissuetacrolimusconcentrationsinadulttransplantrecipientstheinfluenceofthewholebloodandtissueconcentrationsonefficiencyoftreatmentduringimmunosuppressivetherapy